The pharmaceutical industry still faces unrelenting challenges across the entirety of the drug development landscape. According to Piper Sandler’s recent...
Read moreToday marks an important point in our journey to patients as HotSpot Therapeutics announces its $100MM Series C financing. This infusion of…
Read moreReturning to work following the pandemic presents an opportunity to think creatively about how to re-configure the workplace
Read moreToday marks an important milestone for HotSpot Therapeutics as we announce our Series B financing, but it also marks a...
Read moreDNA encoded libraries (DEL) have received a lot of attention over the past few years. They’ve been hailed as “highly...
Read moreThe conventional approach to drug discovery shines a light on specific target proteins, using an arsenal of biochemical and virtual...
Read moreI was excited to participate in Allison Johnson’s recent Biocentury article reflecting on the growing interest of industry in allostery and why...
Read moreAdvances in computational, biophysical and library technologies have driven the emergence of a new drug discovery paradigm with the power...
Read moreThe predictions around the impact of artificial intelligence (AI) have been broad reaching but it’s clear that not everyone is...
Read moreWhat is a regulatory hotspot? A regulatory hotspot is a privileged allosteric site used by nature to regulate the function...
Read more